Skip to content

Public FDA record

Z-2578-2023: ACL TOP Family 50 Series Models as follows: In vitro diagnostic clinical use in the hemostasis laborator

Recall record Z-2578-2023 for Instrumentation Laboratory. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2578-2023
Company in FDA record
Instrumentation Laboratory
FDA classification date
Sep 12, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Sample misidentification could occur under specific conditions and patient management altered based on an incorrectly assigned result

Source facts

Action
UPDATE: 10/16/23: Update relates to additional ACL TOP Family 50 Series instruments that were installed after the field notification was initiated (Phase I), but prior to inclusion of the notification instructions in start-up kits with new production. During the Installation process, Service field representatives will provide the titled Important Instruction, to the customer. The letter states the same instructions as provided in the Urgent Medical Device Correction Letter initially issued. __________________________________________________________________________ Werfen Issued Urgent Medical Device Correction Letter and Mandatory response tracking form on July 13th, 2023 via email or Certified Mail. Letter states reason for recall, health risk and action to take: Based on the above please take one of the following immediate workflows to mitigate this issue. To avoid the potential sample misidentification, users should not change any samples in the sample rack that have been properly identified. If the user decides they must remove a sample from a sample rack that has been properly identified by the ACL TOP Family 50 Series Instrument, they may do so only after the bar code reader has returned to the home position or the samples have been completely resulted. Alternatively, a user may remove a properly identified sample from a sample rack and must leave that sample rack position empty. x Share this information with your laboratory staff and update your internal procedures, as needed. x Forward this notification to all affected locations in your facility. x Post this notification on all affected systems in your facility. x Retain a copy of this notification for your records. x Complete and return the Mandatory Response Tracking Form to acknowledge the above actions. x Mandatory Response Tracking Record x Return the completed and signed Mandatory Response Tracking Form to: x Fax No.: 1-781-861-4207 Or E-mail: ra-usa.na@werfen.com x Contact Information for
Initiated
2023-07-13
Root cause
Under Investigation by firm
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, Finland, Ireland, Lithuania, Malta, Qatar, Sweden.
Recall number
Z-2578-2023
Recall status
Open, Classified
CDRH record ID
202659
FDA classified
2023-09-12
Recall event number
92831

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗